search
Back to results

Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose Homeostasis

Primary Purpose

Diabetes Mellitus, Type 2

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Small mixed protein and lipid meal
Sponsored by
Azienda Ospedaliero, Universitaria Pisana
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Diabetes Mellitus, Type 2

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • healthy, prediabetic or diet-controlled type 2 diabetic patients
  • Subjects ≥ 18 and ≤65 years of age
  • Lean, Overweight or Obese (BMI: 18 to 35 kg/m2)
  • Normal liver and kidney function
  • Normal thyroid function
  • Read and understood the informed consent form and signed it voluntarily

Exclusion Criteria:

  • Liver, heart, kidney, lung, infectious, neurological, psychiatric, immunological or neoplastic diseases.
  • Type 1 or insulin treated diabetes.
  • Pregnancy or lactation
  • Illicit drug abuse or alcoholism
  • Subject treated with insulin or treatment
  • Subjects taking anoretic drugs
  • Subjects on steroid treatment
  • Subjects after bariatric surgery.

Sites / Locations

  • Azienda Ospedaliero-Universitaria Pisana

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Small mixed protein and lipid meal

Arm Description

During the "control" study, each subject ingest 500 ml of water 30 minutes before a standard 75 g Oral Glucose Tolerance Test

During the "preload" study, each subject ingest a small mixed meal 30 minutes before a standard 75 g Oral Glucose Tolerance Test. The meal is composed by 50 g of parmesan cheese, one small size boiled egg and 300 ml of water (250 kcal, 23 g protein, 17 g fat and 2 g of carbohydrate).

Outcomes

Primary Outcome Measures

Plasma glucose response during the Oral Glucose Tolerance Test

Secondary Outcome Measures

Insulin secretion, estimated from C-peptide deconvolution
Insulin sensitivity, estimated from glucose and insulin levels during the Oral Glucose Tolerance Test with the use of Oral Glucose Insulin Sensitivity index
The Oral Glucose Insulin Sensitivity index (OGIS; equation for a 2-h oral glucose test with a glucose dose of 75 g) is the mean glucose clearance change (basal vs OGTT 60-120 min), divided by the mean plasma insulin concentration gradient over the same time interval.
Insulin clearance, estimated by calculating the Insulin secretion/Plasma insulin ratio
Glucose fluxes (intestinal glucose absorption, endogenous glucose production, rate of disappearance of plasma glucose), assessed by modeling glucose tracers enrichments using a standard double tracers technique
Incretin secretion (plasma GLP-1, plasma GIP)
Plasma glucagon
Plasma Non Esterified Fatty Acids
Beta cells function parameters (glucose sensitivity, rate sensitivity, potentiation factor ratio), calculated by modeling insulin secretion and glucose concentration.
Endothelial function assessed as the reactive hyperemia index by an EndoPAT device

Full Information

First Posted
January 13, 2015
Last Updated
March 18, 2020
Sponsor
Azienda Ospedaliero, Universitaria Pisana
search

1. Study Identification

Unique Protocol Identification Number
NCT02342834
Brief Title
Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose Homeostasis
Official Title
Mechanisms Through Which a Small Protein and Lipid Preload Improves Glucose Tolerance in Subjects With Impaired Glucose Homeostasis
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
January 2015 (undefined)
Primary Completion Date
March 2020 (Actual)
Study Completion Date
March 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Azienda Ospedaliero, Universitaria Pisana

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is: to measure the size of the effect on glucose tolerance of a small mixed protein and lipid meal given as a pre-load in individuals with different glucose tolerance status to investigate the underlying mechanisms by accurately evaluating beta cell function, insulin sensitivity, insulin clearance and glucose kinetics (oral absorption, endogenous production, rate of utilization) together with gut hormones plasma concentration.
Detailed Description
As supported by experimental and clinical data, oral carbohydrate tolerance is influenced by the coingestion of nutrients through multiple mechanisms. The ingestion itself, the contact with the gastric mucosa, the arrival into the intestine and the subsequent digestion are known to produce neural reflexes, hormonal responses and plasma substrates gradients which, by modulating gastric emptying, insulin secretion and insulin clearance participate in the regulation of postprandial glycaemia. The size of this effect is influenced by a number of factors: the specific nutrient chemical characteristics (fat vs protein and composition) and their physical properties (solid vs liquid), the timing (pre-load vs coingestion) and finally the individual glucose tolerance status. To our knowledge, the effect on glucose excursions of a combination of protein and fat given before carbohydrate is still unknown and also unknown is the contribution of different mechanisms involved in the control of glucose homeostasis in subjects with different degrees of glucose tolerance.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
35 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
During the "control" study, each subject ingest 500 ml of water 30 minutes before a standard 75 g Oral Glucose Tolerance Test
Arm Title
Small mixed protein and lipid meal
Arm Type
Experimental
Arm Description
During the "preload" study, each subject ingest a small mixed meal 30 minutes before a standard 75 g Oral Glucose Tolerance Test. The meal is composed by 50 g of parmesan cheese, one small size boiled egg and 300 ml of water (250 kcal, 23 g protein, 17 g fat and 2 g of carbohydrate).
Intervention Type
Dietary Supplement
Intervention Name(s)
Small mixed protein and lipid meal
Intervention Description
Ingestion of a small mixed protein and lipid meal 30 minutes before glucose
Primary Outcome Measure Information:
Title
Plasma glucose response during the Oral Glucose Tolerance Test
Time Frame
120 minutes
Secondary Outcome Measure Information:
Title
Insulin secretion, estimated from C-peptide deconvolution
Time Frame
120 minutes
Title
Insulin sensitivity, estimated from glucose and insulin levels during the Oral Glucose Tolerance Test with the use of Oral Glucose Insulin Sensitivity index
Description
The Oral Glucose Insulin Sensitivity index (OGIS; equation for a 2-h oral glucose test with a glucose dose of 75 g) is the mean glucose clearance change (basal vs OGTT 60-120 min), divided by the mean plasma insulin concentration gradient over the same time interval.
Time Frame
120 minutes
Title
Insulin clearance, estimated by calculating the Insulin secretion/Plasma insulin ratio
Time Frame
120 minutes
Title
Glucose fluxes (intestinal glucose absorption, endogenous glucose production, rate of disappearance of plasma glucose), assessed by modeling glucose tracers enrichments using a standard double tracers technique
Time Frame
120 minutes
Title
Incretin secretion (plasma GLP-1, plasma GIP)
Time Frame
120 minutes
Title
Plasma glucagon
Time Frame
120 minutes
Title
Plasma Non Esterified Fatty Acids
Time Frame
120 minutes
Title
Beta cells function parameters (glucose sensitivity, rate sensitivity, potentiation factor ratio), calculated by modeling insulin secretion and glucose concentration.
Time Frame
120 minutes
Title
Endothelial function assessed as the reactive hyperemia index by an EndoPAT device
Time Frame
fasting, 60 min and 120 min during the control and preload OGTT

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: healthy, prediabetic or diet-controlled type 2 diabetic patients Subjects ≥ 18 and ≤65 years of age Lean, Overweight or Obese (BMI: 18 to 35 kg/m2) Normal liver and kidney function Normal thyroid function Read and understood the informed consent form and signed it voluntarily Exclusion Criteria: Liver, heart, kidney, lung, infectious, neurological, psychiatric, immunological or neoplastic diseases. Type 1 or insulin treated diabetes. Pregnancy or lactation Illicit drug abuse or alcoholism Subject treated with insulin or treatment Subjects taking anoretic drugs Subjects on steroid treatment Subjects after bariatric surgery.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrea Natali, Professor
Organizational Affiliation
Azienda Ospedaliero, Universitaria Pisana
Official's Role
Study Chair
Facility Information:
Facility Name
Azienda Ospedaliero-Universitaria Pisana
City
Pisa
State/Province
PI
ZIP/Postal Code
56127
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
30008106
Citation
Trico D, Frascerra S, Baldi S, Mengozzi A, Nesti L, Mari A, Natali A. The insulinotropic effect of a high-protein nutrient preload is mediated by the increase of plasma amino acids in type 2 diabetes. Eur J Nutr. 2019 Sep;58(6):2253-2261. doi: 10.1007/s00394-018-1778-y. Epub 2018 Jul 14.
Results Reference
derived
PubMed Identifier
26224101
Citation
Trico D, Baldi S, Tulipani A, Frascerra S, Macedo MP, Mari A, Ferrannini E, Natali A. Mechanisms through which a small protein and lipid preload improves glucose tolerance. Diabetologia. 2015 Nov;58(11):2503-12. doi: 10.1007/s00125-015-3710-9. Epub 2015 Jul 30.
Results Reference
derived

Learn more about this trial

Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose Homeostasis

We'll reach out to this number within 24 hrs